Cargando…

Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity

BACKGROUND: The vasoactive intestinal peptide (VIP) receptors VPAC1 and VPAC2 mediate anti-inflammatory and immunoregulatory responses in rheumatoid arthritis (RA). Data on the expression of these receptors could complement clinical assessment in the management of RA. Our goal was to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seoane, Iria V., Ortiz, Ana M., Piris, Lorena, Lamana, Amalia, Juarranz, Yasmina, García-Vicuña, Rosario, González-Álvaro, Isidoro, Gomariz, Rosa P., Martínez, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755558/ https://www.ncbi.nlm.nih.gov/pubmed/26881970 http://dx.doi.org/10.1371/journal.pone.0149141

Ejemplares similares

An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance
por: Gomariz, Rosa P., et al.
Publicado: (2019)

Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis
por: Martínez, Carmen, et al.
Publicado: (2014)

Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis
por: Seoane, Iria V., et al.
Publicado: (2018)

Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity
por: Seoane, Iria V., et al.
Publicado: (2015)

Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence
por: Villanueva-Romero, Raúl, et al.
Publicado: (2020)

VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Disorders: Associated miRNA Signatures
por: Lamana, Amalia, et al.
Publicado: (2022)

The Anti-Inflammatory Mediator, Vasoactive Intestinal Peptide, Modulates the Differentiation and Function of Th Subsets in Rheumatoid Arthritis
por: Villanueva-Romero, Raúl, et al.
Publicado: (2018)

The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis
por: Castro-Vazquez, David, et al.
Publicado: (2021)

A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases
por: Martínez, Carmen, et al.
Publicado: (2019)

Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity
por: Lamana, Amalia, et al.
Publicado: (2020)

The pathogenic Th profile of human activated memory Th cells in early rheumatoid arthritis can be modulated by VIP
por: Jimeno, Rebeca, et al.
Publicado: (2014)

Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
por: Juarranz, Yasmina, et al.
Publicado: (2005)

Biomarkers Predicting a Need for Intensive Treatment in Patients with Early Arthritis
por: I, González-Álvaro, et al.
Publicado: (2015)

VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts
por: Pérez‐García, Selene, et al.
Publicado: (2016)

The Minor Allele of rs7574865 in the STAT4 Gene Is Associated with Increased mRNA and Protein Expression
por: Lamana, Amalia, et al.
Publicado: (2015)

Human CD4(+)CD45RA(+) T Cells Behavior after In Vitro Activation: Modulatory Role of Vasoactive Intestinal Peptide
por: Villanueva-Romero, Raúl, et al.
Publicado: (2022)

Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin
por: Pérez-García, Selene, et al.
Publicado: (2019)

Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2020)

Genetic LGALS1 Variants Are Associated with Heterogeneity in Galectin-1 Serum Levels in Patients with Early Arthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2022)

Role of VPAC1 and VPAC2 receptors in the etiology of pregnancy rhinitis: an experimental study in rats
por: Ulkumen, Burak, et al.
Publicado: (2020)

Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.
por: Castañeda, Santos, et al.
Publicado: (2017)

Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2022)

Seasonal changes in the expression of PACAP, VPAC1, VPAC2, PAC1 and testicular activity in the testis of the muskrat (Ondatra zibethicus)
por: Tang, Zeqi, et al.
Publicado: (2022)

PAC(1), VPAC(1), and VPAC(2) Receptor Expression in Rat and Human Trigeminal Ganglia: Characterization of PACAP-Responsive Receptor Antibodies
por: Tasma, Zoe, et al.
Publicado: (2022)

Understanding VPAC receptor family peptide binding and selectivity
por: Piper, Sarah J., et al.
Publicado: (2022)

Inhibitory Role of Growth Hormone in the Induction and Progression Phases of Collagen-Induced Arthritis
por: Villares, Ricardo, et al.
Publicado: (2018)

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease
por: Carrión, M., et al.
Publicado: (2020)

Expression of VPAC1 in a murine model of allergic asthma
por: Lauenstein, Hans D, et al.
Publicado: (2013)

Diagnosis of Oral Cancers by Targeting VPAC Receptors: Preliminary Report
por: Nerli, Rajendra, et al.
Publicado: (2023)

Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients
por: Villanueva-Romero, R., et al.
Publicado: (2019)

Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients
por: Llorente, Irene, et al.
Publicado: (2017)

The TT Genotype of the STAT4 rs7574865 Polymorphism Is Associated with High Disease Activity and Disability in Patients with Early Arthritis
por: Lamana, Amalia, et al.
Publicado: (2012)

Proteomic Analysis of Synovial Fibroblasts and Articular Chondrocytes Co-Cultures Reveals Valuable VIP-Modulated Inflammatory and Degradative Proteins in Osteoarthritis
por: Pérez-García, Selene, et al.
Publicado: (2021)

VPAC: Variational projection for accurate clustering of single-cell transcriptomic data
por: Chen, Shengquan, et al.
Publicado: (2019)

Molecular and Cellular Basis of Autoimmune Diseases
por: Juarranz, Yasmina
Publicado: (2021)

Development by Genetic Immunization of Monovalent Antibodies Against Human Vasoactive Intestinal Peptide Receptor 1 (VPAC1), New Innovative, and Versatile Tools to Study VPAC1 Receptor Function
por: Peyrassol, Xavier, et al.
Publicado: (2018)

Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of hippocampal precursor cells via IL-4 release
por: Nunan, Robert, et al.
Publicado: (2014)

The VPAC1 receptor: structure and function of a class B GPCR prototype
por: Couvineau, A., et al.
Publicado: (2012)

Wnt and RUNX2 mediate cartilage breakdown by osteoarthritis synovial fibroblast‐derived ADAMTS‐7 and ‐12
por: Pérez‐García, Selene, et al.
Publicado: (2019)

Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies
por: Langer, Ingrid
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_feuuif4fp9a18jocoq35od1fjd